logo
Plus   Neg
Share
Email

UroGen Pharma Ltd. (URGN) Rose Past Resistance At The Highs

UroGen Pharma Ltd. (URGN) gapped open higher Tuesday and climbed throughout the first half of the afternoon. Shares finished with a gain of 11.45 at $59.80 with volume at a 2 1/2 month high.

UroGen Pharma broke out past resistance Tuesday and set a new high for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT